🇺🇸 FDA
Patent

US 11180765

Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

granted A61KA61K2035/11A61K2039/522

Quick answer

US patent 11180765 (Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2035/11, A61K2039/522, A61K2039/523, A61K35/74